{"disease":{"id":"uveitis-intermediate","name":"uveitis intermediate"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06431373","title":"A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":371,"lead_sponsor_name":"Priovant Therapeutics, Inc.","has_results":false},{"nct_id":"NCT02595398","title":"Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Clearside Biomedical, Inc.","has_results":true},{"nct_id":"NCT02746991","title":"Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":153,"lead_sponsor_name":"EyePoint Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03097315","title":"Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Clearside Biomedical, Inc.","has_results":true},{"nct_id":"NCT05953688","title":"POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":36,"lead_sponsor_name":"Alumis Inc","has_results":false},{"nct_id":"NCT02952001","title":"MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301","phase":"","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Clearside Biomedical, Inc.","has_results":true},{"nct_id":"NCT06085079","title":"Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Massachusetts Eye Research and Surgery Institution","has_results":false},{"nct_id":"NCT05070728","title":"Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"EyePoint Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04126850","title":"Pilot Project: The Amplicon and Metatranscriptomic Study of Intra and Extra Intestinal Microbiome in Non-infectious Uveitis Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":10,"lead_sponsor_name":"Fakultas Kedokteran Universitas Indonesia","has_results":false},{"nct_id":"NCT02764697","title":"Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Tampa Bay Uveitis Center, LLC","has_results":true},{"nct_id":"NCT03656692","title":"Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Mallinckrodt","has_results":true},{"nct_id":"NCT05101928","title":"Ozurdex Monotherapy Trial","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Ottawa Hospital Research Institute","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}